eveliqure.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.eveliqure.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Biotech Company | Eveliqure Biotechnologies |
Description Smarter Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income
Keywords N/A
Server Information
WebSite eveliqure faviconeveliqure.com
Host IP 23.236.62.147
Location United States
Related Websites
Site Rank
More to Explore
everyingredient.org
everythingsciencefiction.com
evolve.fans
evolvfitnessco.com
excelappliancerepairs.com
exdgroup.com
exoticautocars.com
experienceatrium.com
externalhikingbook.com
eyeclinicsmi.com
eyehomes.com
ezyhire.com
fabiomarini.net
factworks.com
fadedstatusapparel.squarespace.com
familyshop668.net
fancoustom.com
fancynicely.store
fbcglenarden.com
fbodyfutures.com
eveliqure.com Valuation
US$886,834
Last updated: 2023-05-18 17:43:23

eveliqure.com has Semrush global rank of 11,934,933. eveliqure.com has an estimated worth of US$ 886,834, based on its estimated Ads revenue. eveliqure.com receives approximately 102,327 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, eveliqure.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$886,834
Daily Ads Revenue US$819
Monthly Ads Revenue US$24,559
Yearly Ads Revenue US$294,702
Daily Unique Visitors 6,822
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
eveliqure.com. A 3600 IP: 23.236.62.147
eveliqure.com. NS 3600 NS Record: ns2.easyname.eu.
eveliqure.com. NS 3600 NS Record: ns1.easyname.eu.
eveliqure.com. MX 3600 MX Record: 0 eveliqure-com.mail.protection.outlook.com.
eveliqure.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
eveliqure.com. TXT 3600 TXT Record: MS=ms51594709
HtmlToTextCheckTime:2023-05-18 17:43:23
top of page HOME Vision & Mission Management team Board Financing Problem Our solution How it works Status Strategy NEWS CONTACT US Smarter vaccines About us_home Eveliqure announces the publication of positive Phase I clinical data for its vaccine candidate against Shigellosis and ETEC Read more Eveliqure announces the award of a NIAID contract to finance Phase 2 clinical studies of its combined Shigella and ETEC vaccine candidate Read more About Eveliqure Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. Eveliqure has developed a novel vaccine technology platform based on a live attenuated vaccine strain of the bacterium Shigella, engineered to induce broad protection against infection caused by different species and serotypes of this pathogen. In addition, Eveliqure has introduced the expression of non-shigella
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 09 Jul 2022 08:49:47 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.eveliqure.com/
strict-transport-security: max-age=3600
Age: 67322
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhT9gRHUF6iCEZerWBFcnqX,m0j2EEknGIVUW/liY8BLLl77sBeKLtHVaXbFQUDNQYPu/2EjeiyKjB/JVOb8T5Ve,2d58ifebGbosy5xc+FRalsWuhmPdcW445daOuvau80d+I/kesLb2QXlgKpin6vEixzbx6AcXDih4bewiRb50hw==,2UNV7KOq4oGjA5+PKsX47I1RUfM+Gm2tbtCPQhpreUgfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1657356587.6384100474112110976
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 09 Jul 2022 08:49:48 GMT
content-type: text/html; charset=UTF-8
content-length: 261095
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"27010e6bf93a55b01fbcafc3e39632d8"
content-language: en-US
strict-transport-security: max-age=3600
age: 62324
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Fri, 08 Jul 2022 15:31:23 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YSbeVuV5XuEedv5aSxQjcK0=,vmPhUNXuQemvc7fjBI8NWewfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVivd4o9HMoDTVPhK7/s60Jl,m0j2EEknGIVUW/liY8BLLqz32kGg/0+YmoIOWNy6M58a0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalh4LGZruo8uHTURqrM/mE9fGUfO4yH9bbi+WVrEi4dRupBJzGEeZ6X0F76NoEesJUQ==,2UNV7KOq4oGjA5+PKsX47Av6H0zmMzTB+NKnQKY4mNEfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1657356588.2554099247360137727
x-content-type-options: nosniff
set-cookie: TS01e85bed=01c46356a78b8630e552ed7b1d330e4a6fd22106cfbe48b8fbb2538f576814311ee20f01c4e92965568931dc5f3365f19238ba97de; Path=/; SameSite=none; Secure
server: Pepyaka/1.19.10
eveliqure.com Whois Information
Domain Name: EVELIQURE.COM
Registry Domain ID: 1705609441_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enterprice.net
Registrar URL: http://www.epag.de
Updated Date: 2022-03-02T21:17:44Z
Creation Date: 2012-03-05T16:01:51Z
Registry Expiry Date: 2023-03-05T16:01:51Z
Registrar: EPAG DOMAINSERVICES GmbH
Registrar IANA ID: 85
Registrar Abuse Contact Email: legal@tucows.com
Registrar Abuse Contact Phone: +1.4165350123
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.EASYNAME.EU
Name Server: NS2.EASYNAME.EU
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-09T08:53:14Z <<<